Eps Diluted - Protagonist Therapeutics Inc (NASDAQ:PTGX) - Alpha Spread

Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 45.92 USD 2.57% Market Closed
Market Cap: 2.7B USD
Have any thoughts about
Protagonist Therapeutics Inc?
Write Note

Protagonist Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Protagonist Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Protagonist Therapeutics Inc
NASDAQ:PTGX
EPS (Diluted)
$2
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$2
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-15%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$5
CAGR 3-Years
-17%
CAGR 5-Years
-15%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
-$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$37
CAGR 3-Years
-13%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Protagonist Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
2.8 USD

Based on the financial report for Jun 30, 2024, Protagonist Therapeutics Inc's EPS (Diluted) amounts to 2.8 USD.

Back to Top